Page 137 - MemoriaEHD-Eng

www.ciberehd.org

Most relevant • FerNáNDez-Bañares F, De sousa Mr, saLas a, BeLtráN B, piQueras M, igLesias e. Impact
of current smoking on the clinical course of microscopic colitis.Inflamm Bowel Dis.
scientific
2013 Jun;19(7):1470-6.
articles
• FerNáNDez-Bañares F, De sousa Mr, saLas a, BeLtráN B, piQueras M, igLesias e. Epidemio-
logical risk factors in microscopic colitis: a prospective case-control study.Inflamm

Bowel Dis. 2013 Feb;19(2):411-7.

• CarrasCo a, Mañe J, saNtaoLaLLa r, peDrosa e, MaLLoLas J, LoréN v. Comparison of lympho-
cyte isolation methods for endoscopic biopsy specimens from the colonic mucosa.J

Immunol Methods. 2013 Mar 29;389(1-2):29-37.

• paNés J, López-saNroMáN a, BerMeJo F, garCía-sáNChez v, esteve M, torres y. Early azathio-

prine therapy is no more effective than placebo for newly diagnosed Crohn’s disease.
Gastroenterology. 2013 Oct;145(4):766-74.e1.

• JuLià a, DoMèNeCh e, riCart e, tortosa r, garCía-sáNChez v, gisBert Jp. A genome-wide

association study on a southern European population identifies a new Crohn’s disea-
se susceptibility locus at RBX1-EP300.Gut. 2013 Oct;62(10):1440-5.
á

• CELIAC DISEASE: Publications 2013: Monzon H. World J Gastroenterol 2013. é
Highlights
Projects: “Immunopatogenesis of lymphocytic enteritis due to gluten sensitive á

enteropathy: Diagnostic and physiopathological assessment” and “OMIC“ ñ
üé
analysis for lymphocytic enteritis diagnosis secondary to gluten-sensitive
enteropathy (PI10/00892 y PI13/02499, PI:FFernández- Bañares), “Natural

history of celiac disease: longitudinal long term study to assess the evolution of
ñ
serological markers of CD and histology in children 1 to 4 years old”(PI13/00413;
PI: M Marin).

• MICROSCOPIC COLITIS: Publications 2013 leaded by our group: RECOMINA

project: Fernndez- Baares F et al. inflamado Bowel Dis 2013; 19:1470-6 y

Fernndez - Baares F et al. Inflam Bowel Dis 2013; 19: 411-7) and international
clinical trials Mnch A, Fernandez-Bañares F, Munck LK. Azathioprine and

mercaptopurine in the management of patient with chronic, active microscopic
à
colitis. Aliment Pharmacol Ther 2013; 37:795-8).

• INFLAMMATORY BOWEL DISEASE (IBD): Publications 2013 leaded by our
group: Carrasco A. J Immunol Methods. 2013;389:29-37. Projects: “Role

of interleukin Il -10 to the pathophysiology of drug refractoriness in Crohn’s

disease. Relationship between apoptosis of T and B lymphocytes” (PI:MEsteve,
BFU - BFI 2010-19888) and “Multicenter prospective randomized comparative

study of endoscopic treatment of strictures in Crohn’s disease: self-expanding
metal stents vs dilation” (PI:C.Loras, PI13/01226). Collaborative Publications:

(ENEIDA and INNP-BMK-IMID projects): Nunes T. Aliment Pharmacol Ther 2013;

38: 752-60; Pans J. Gastroenterology 2013;145:766-74; Mañosa M. Inflamm 13
Bowel Dis 2013;19:1889-95; Chaparro M. Inflamm Bowel Dis 2013;19:1404- 20
T
10; Zabala W. Pharmacogenomics 2013;14:631-40; Casanova MJ. Am J OR
P
Gastroenterol. 2013; 108: 433-40; Juli A. Gut. 2013; 62:1440-5; Cabriada JL. RE
Gastroenterol Hepatol 2013;36:127-46.
L
A
NU
N
A
D /
H
E
ER
IB
C

137